mounjaro tirzepatide 10mg 10mg/0.6mL KwikPen 2.4 mL - tirzepatide helps to lower blood sugar levels and improve insulin sensitivity mounjaro 10 mg x 0.5

Half the peptide means roughly half the price, making initial experimentation more accessible

150.00 Original price was: 150.00.102.50Current price is: 102.50

Higher baseline inflammatory markers like IL6 and TNF track with more heart disease, diabetes, cognitive decline, and earlier mortality in older adults. With tirzepatide on board, that background fire drops: It lowers proinflammatory cytokines: Animal and cell studies show tirzepatide cuts classic inflammatory messengers, including IL6, IL1, and TNF, while boosting antiinflammatory cytokines like IL4 and IL10. It calms hot metabolic tissues: In obese mice, tirzepatide reduces inflammatory macrophages in visceral fat and improves insulin signaling as that tissue quiets down. GLP1based drugs with similar signaling reduce vascular and kidney inflammation, which lines up with the lower cardiovascular and kidney event rates seen in large outcome trials. Turn that into real life and you get less background ache, less immune noise beating up vessels and organs, and a lower inflammatory drag on the heart, brain, and kidneys as the decades add up

Jensterle Sever M, Kocjan T, Pfeifer M, Kravos NA, Janez A (2014) Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin

Retatrutide (Triple Agonist) Simultaneously activates: GLP-1 GIP Glucagon receptors This broader receptor profile supports advanced research into integrated metabolic and endocrine signalling

The data in the FAERS database covered from the second quarter of 2022 (the quarter in which tirzepatide was approved by the FDA) to the third quarter of 2024 (the most recent quarter available at the start of this study, posted on 30-Oct-2024)